In vivo analysis shows NT-0527 reduces inflammation in neuroinflammatory disorders, suggesting a new approach for treatment.
NT-0527 is a potent, specific and brain penetrant NLRP3 inflammasome inhibitor with oral bioavailability and efficacy in an in vivo model of inflammation.
No takes yet. Share an insight, caveat, or question.
Harrison et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: